Alemtuzumab improves contrast sensitivity in patients with relapsing–remitting multiple sclerosis

BACKGROUND: Alemtuzumab is a monoclonal antibody directed against CD52 that depletes T and B lymphocytes. OBJECTIVE: To evaluate the treatment effect of alemtuzumab on low-contrast vision in relapsing–remitting multiple sclerosis (RRMS) patients. METHODS: This was a pre-defined exploratory analysis...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Graves, Jennifer, Galetta, Steven L, Palmer, Jeffrey, Margolin, David H, Rizzo, Marco, Bilbruck, John, Balcer, Laura J
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2013
Fag:
Research Papers
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3807733/
https://ncbi.nlm.nih.gov/pubmed/23459567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458513475722
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker